Skip to main content
. 2011 Sep 27;20(1):230–238. doi: 10.1038/mt.2011.195

Figure 2.

Figure 2

Kinetics of white blood cells (WBCs) and peripheral blood CD34+ cells in splenectomized (SPL) patients and the mean yield of CD34+ cells per patient per apheresis. (a) Kinetics of WBCs and peripheral blood CD34+ cells in the SPL patients treated with G-CSF or HU+G-CSF (with the long washout period) or plerixafor. (b) The mean yield per patient per apheresis in SPL subjects treated with granulocyte-colony stimulating factor (G-CSF), HU+G-CSF (with the long washout period), plerixafor and plerixafor + G-CSF. (c) The mean yield per patient per apheresis in non-SPL subjects treated with G-CSF, HU+G-CSF (with the long washout period), and plerixafor. *P = 0.02 versus G-CSF, #P = 0.09 versus G-CSF. HU, hydroxyurea.